These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27712511)

  • 1. Anakinra in resistant gout: a case report.
    Van Wabeke J; Dhondt E; Peene I; Piette Y
    Acta Clin Belg; 2017 Aug; 72(4):293-295. PubMed ID: 27712511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.
    Tran AP; Edelman J
    Int J Rheum Dis; 2011 Aug; 14(3):e33-7. PubMed ID: 21816011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra treatment in patients with gout and type 2 diabetes.
    Vitale A; Cantarini L; Rigante D; Bardelli M; Galeazzi M
    Clin Rheumatol; 2015 May; 34(5):981-4. PubMed ID: 24733251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 inhibition with anakinra in a patient with refractory gout.
    Singh D; Huston KK
    J Clin Rheumatol; 2009 Oct; 15(7):366. PubMed ID: 20009976
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of anakinra as a steroid-sparing agent for gout inflammation.
    Gratton SB; Scalapino KJ; Fye KH
    Arthritis Rheum; 2009 Sep; 61(9):1268-70. PubMed ID: 19714614
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of Anakinra in Acute Gout: A Retrospective Review of Initial and Refractory Therapy.
    Petite SE
    Am J Ther; 2017; 24(5):e633-e634. PubMed ID: 27763889
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute gout.
    Schlesinger N
    Rheum Dis Clin North Am; 2014 May; 40(2):329-41. PubMed ID: 24703350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra's efficacy is variable in refractory gout: report of ten cases.
    Chen K; Fields T; Mancuso CA; Bass AR; Vasanth L
    Semin Arthritis Rheum; 2010 Dec; 40(3):210-4. PubMed ID: 20494407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of the interleukin 1 antagonist, anakinra, in a patient with gout, chronic kidney disease, and aplastic anemia.
    Bartov JB; Ali Y
    J Clin Rheumatol; 2013 Dec; 19(8):454-6. PubMed ID: 24263151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications of anakinra].
    Chauffier K; London J; Beaudouin C; Fautrel B
    Presse Med; 2009 May; 38(5):799-807. PubMed ID: 19278814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases.
    Thomas M; Forien M; Palazzo E; Dieudé P; Ottaviani S
    Clin Rheumatol; 2019 Feb; 38(2):425-430. PubMed ID: 30145636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin-1 inhibitors in the management of gout.
    Tran TH; Pham JT; Shafeeq H; Manigault KR; Arya V
    Pharmacotherapy; 2013 Jul; 33(7):744-53. PubMed ID: 23553601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.
    McGonagle D; Tan AL; Shankaranarayana S; Madden J; Emery P; McDermott MF
    Ann Rheum Dis; 2007 Dec; 66(12):1683-4. PubMed ID: 17998217
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Anakinra in Hospitalized Patients with Crystal-associated Arthritis.
    Liew JW; Gardner GC
    J Rheumatol; 2019 Oct; 46(10):1345-1349. PubMed ID: 30647192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First observation of the efficacy of IL-1ra to treat tophaceous gout of the lumbar spine.
    Funck-Brentano T; Salliot C; Leboime A; Zafrani L; Servais A; Larousserie F; Dougados M
    Rheumatology (Oxford); 2011 Mar; 50(3):622-4. PubMed ID: 21097448
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.
    Loustau C; Rosine N; Forien M; Ottaviani S; Juge PA; Lioté F; Bardin T; Richette P; Dieudé P; Richez C; Bannwarth B; Schaeverbeke T; Ea HK; Truchetet ME
    Joint Bone Spine; 2018 Dec; 85(6):755-760. PubMed ID: 29654950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis.
    Moltó A; Ea HK; Richette P; Bardin T; Lioté F
    Joint Bone Spine; 2012 Dec; 79(6):621-3. PubMed ID: 22658375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic tophaceous gout.
    Dönmez S; Pamuk ÖN
    J Rheumatol; 2014 Mar; 41(3):554-5. PubMed ID: 24585523
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L; Marchetti F; Tommasini A; Ventura A
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
    Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
    Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.